We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
NetApp
NTAP
$32.9B
| $17.4M | 0.25% |
251,302
+22,950
| +10% | +$1.48M |
|
102
Occidental Petroleum
OXY
$57B
| $17.3M | 0.25% |
260,706
-418,400
| -62% | -$27.6M |
|
103
JPMorgan Chase
JPM
$939B
| $17.2M | 0.25% |
169,780
-4,250
| -2% | -$438K |
|
104
Synaptics
SYNA
$4.41B
| $17.1M | 0.25% |
429,920
+81,580
| +23% | +$3.22M |
|
105
Jazz Pharmaceuticals
JAZZ
$15.9B
| $17.1M | 0.25% |
+119,304
| New | +$15.6M |
|
106
Western Digital
WDC
$179B
| $17M | 0.25% |
469,054
-79,724
| -15% | -$2.73M |
|
|
107
Vertex Pharmaceuticals
VRTX
$121B
| $17M | 0.25% |
92,342
-230,348
| -71% | -$42.5M |
|
108
Coca-Cola
KO
$354B
| $16.9M | 0.24% |
360,530
-236,730
| -40% | -$11.1M |
|
|
MNDT
109
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $16.6M | 0.24% |
989,523
+243,190
| +33% | +$4.09M |
|
110
Intercontinental Exchange
ICE
$82.4B
| $16.5M | 0.24% |
216,700
+148,830
| +219% | +$11.1M |
|
111
Qualcomm
QCOM
$176B
| $16.4M | 0.24% |
288,400
+228,540
| +382% | +$12.3M |
|
112
Avnet
AVT
$7.33B
| $15.8M | 0.23% |
365,425
-142,129
| -28% | -$6M |
|
113
Madison Square Garden
MSGS
$9.54B
| $15.7M | 0.23% |
74,872
-26,638
| -26% | -$5.41M |
|
114
Align Technology
ALGN
$12B
| $15.1M | 0.22% |
53,231
-540
| -1% | -$129K |
|
115
Idexx Laboratories
IDXX
$42.9B
| $14.8M | 0.21% |
66,103
-6,701
| -9% | -$1.38M |
|
|
SPLK
116
DELISTED
Splunk Inc
SPLK
| $14.7M | 0.21% |
118,210
-7,410
| -6% | -$925K |
|
117
Evercore
EVR
$13.1B
| $14.7M | 0.21% |
160,990
+41,309
| +35% | +$3.63M |
|
118
Hartford Financial Services
HIG
$38.5B
| $14.6M | 0.21% |
293,889
-144,380
| -33% | -$6.86M |
|
119
American Tower
AMT
$77.7B
| $14.6M | 0.21% |
+74,140
| New | +$13M |
|
120
Quanta Services
PWR
$93.9B
| $14.6M | 0.21% |
386,890
-81,373
| -17% | -$2.84M |
|
121
Cisco
CSCO
$450B
| $14.6M | 0.21% |
270,320
-139,030
| -34% | -$6.76M |
|
|
NAV
122
DELISTED
Navistar International
NAV
| $14.5M | 0.21% |
450,165
+86,340
| +24% | +$2.87M |
|
123
Workiva
WK
$2.94B
| $14.3M | 0.21% |
281,597
+75,790
| +37% | +$3.33M |
|
124
Pentair
PNR
$10.2B
| $14.2M | 0.21% |
319,870
+6,440
| +2% | +$268K |
|
125
Progress Software
PRGS
$1.55B
| $14.2M | 0.2% |
318,983
+220,461
| +224% | +$8.06M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.